Clinical Trials on Graft-versus-host-disease in New Zealand
Total 4106 results
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedGraft-versus-Host Disease | Immune System DisordersUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
MedImmune LLCCompletedGraft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedRecruitingGraft Versus Host Disease, AcuteUnited States, Australia, Turkey
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
Dartmouth-Hitchcock Medical CenterTerminatedChronic Graft-versus-host-diseaseUnited States
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
AmgenCompletedChronic Graft-versus-Host Disease (cGVHD)Australia
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.CompletedGraft vs Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Leukemia | Hematopoietic and Lymphoid System NeoplasmUnited States, Canada
-
McMaster UniversitySanofi; Ozmosis Research Inc.; Cell Therapy Transplant CanadaRecruitingAcute Leukemia | Myelodysplasia | Chronic Graft-versus-host-diseaseCanada, Australia
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Millennium Pharmaceuticals, Inc.TerminatedAllogeneic Hematopoietic Stem Cell TransplantationUnited States, Belgium, Sweden, France, Norway
-
Kadmon, a Sanofi CompanyTerminatedEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyChronic Graft-versus-host-diseaseUnited States
-
Fred Hutchinson Cancer CenterSanofiRecruitingChronic Graft Versus Host DiseaseUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Graft Versus Host DiseaseUnited States
-
University of British ColumbiaActive, not recruitingChronic Graft vs Host DiseaseCanada, United States, Austria
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Washington... and other collaboratorsActive, not recruiting
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
Incyte CorporationRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host DiseaseUnited States, Canada
-
Incyte CorporationTerminatedHematologic MalignanciesUnited States, Spain, France, Italy
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
John LevineNational Cancer Institute (NCI)CompletedGVHD | Graft-versus-host-diseaseUnited States
-
Martin, PaulNational Cancer Institute (NCI)TerminatedCancerUnited States, Canada
-
SoligenixTerminatedAcute Gastrointestinal Graft vs Host DiseaseUnited States
-
Emory UniversityBristol-Myers Squibb; Thrasher Research Fund; Sickle Cell Transplant Advocacy... and other collaboratorsActive, not recruitingGraft Versus Host DiseaseUnited States
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Argentina, Belgium, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Denmark, Brazil
-
Mesoblast, Inc.CompletedGraft Vs Host DiseaseUnited States
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Lee, StephanieNational Cancer Institute (NCI)CompletedSystemic Scleroderma | Graft Versus Host DiseaseUnited States
-
John LevineRecruitingAdverse Effects | Acute Graft vs Host Disease | Allogeneic Bone Marrow TransplantationUnited States, Canada
-
Baxalta now part of ShireTerminatedLymphoma | Leukemia | Graft Versus Host DiseaseUnited States, Australia
-
Fate TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia | Hematologic Malignancies | Acute Graft-versus-host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedAcute Leukemia | MyelodysplasiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Chimeric TherapiesCompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Graft Versus Host DiseaseUnited States
-
Monica BhatiaActive, not recruitingSickle Cell Disease | Graft Versus Host DiseaseUnited States